financetom
Business
financetom
/
Business
/
Charter Communications Likely to See Revenue, EBITDA Growth in Q3, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Charter Communications Likely to See Revenue, EBITDA Growth in Q3, UBS Says
Sep 27, 2024 5:06 PM

04:05 PM EDT, 09/26/2024 (MT Newswires) -- Charter Communications ( CHTR ) is likely to see revenue and earnings before interest, taxes, depreciation and amortization grow year-over-year in Q3, UBS Securities said in a note Thursday.

Q3 revenue and EBITDA are expected to grow 0.9% and 3.2%, respectively, an increase from year-over-year growth of 0.2% and 2.6% respectively in Q2, the investment firm said.

On July 26, the company reported Q2 revenue of $13.69 billion, up from $13.66 billion a year earlier.

The company is expected to experience higher broadband subscriber losses in Q3 and Q4 due to non-paying customers being disconnected, UBS said. Despite this, Charter is still expected to achieve positive revenue and EBITDA growth, driven by price increases, lower costs, and political advertising, the note said.

For the full year, Charter is maintaining its estimates for revenue and EBITDA growth, but expects growth to slow down in 2025 as the impact of broadband losses and the decline in political advertising spending becomes more apparent, UBS said.

"We expect [Q3] EBITDA to grow at 3.2%, accelerating from 2.6% in Q2 as July price increases, lower costs and ramping political advertising support trends," UBS said.

UBS has a neutral rating on Charter with a $325 price target.

Price: 317.18, Change: +2.69, Percent Change: +0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved